TP53 and cancer: Conversely, conditional overexpression of SIRT1 was shown to reduce the tumor burden in p53 (+/−) mice, promote genomic stability in vivo, and inhibit the NF-κB pathway, responsible for metastasis and cancer cell survival [110,111,112].